Auto Injectors Market to Reach $3.78 billion with 19.42% CAGR Forecast to 2022
Auto Injectors -Market Demand, Growth, Opportunities and Forecast 2016 - 2020
PUNE, INDIA, July 27, 2016 /EINPresswire.com/ -- About Auto Injectors MarketSummary
According to Stratistics MRC, the Global Auto Injectors Market is accounted for $1.10 billion in 2015 and is expected to reach $3.78 billion by 2022 growing at a CAGR of 19.42%. As large number of patients are opting for self administered treatment and care there is a flawless increase in use of Auto Injectors. Moreover, the high prevailing patients of anaphylaxis had presented a huge demand for the market which seems as pertaining factor behind the market growth. At the same time high cost and need for utmost care are some of the factors hampering the market.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/562722-auto-injectors-global-market-outlook-2015-2022
Prefilled Syringes in primary drug container segment seems to be predominant in market segment because of the dramatic effect on the way injectable drugs are developed, prescribed and administered. Anaphylaxis in the therapeutic application segment will be dominant throughout the forecast period, as more people are allergic and nauseous. While North America being the largest market, Asia pacific hails as fastest growing because of channeling investments into China and India and improving consumer awareness through marketing campaigns.
Some of the major key players of the market are
Unilife Corporation, Novartis International AG, Becton, Dickinson and Company, Antares Pharma, Inc., Mylan, Inc., Adamis Pharmaceuticals Corp, Hospira Inc, Scandinavian Health Limited (SHL) Group, Sanofi SA, Itelliject Inc , Pfizer, Inc., Lincoln Medical Ltd, Ypsomed Holdings AG, ALK Abello, Teva Pharmaceuticals Ltd and Biogen Idec, Inc.
Devices Covered:
• Smart Autoinjectors
• Product Specific Autoinjectors
• Manual Injection Autoinjectors
• Disposable Autoinjectors
• Reusable Autoinjectors
• Variable Dose Autoinjectors
• Automated Injection Autoinjectors
Product Types Covered:
• Standardized Auto-injectors
• Customized Auto-injectors
Therapeutic Applications covered:
• Autoimmune Diseases
• Anaphylaxis
• Anticoagulants
• Neurology
• Rheumatoid Arthritis
• Infectious Diseases
• Reproductive Health
• Hormones
• Hematopoietics
• Multiple Sclerosis
• Emergency Medicine
• Other Therapeutic Application
Primary Drug Containers Covered:
• Cartridges
o Single Chamber Cartridge
o Dual Chamber Cartridge
• Vials
• Prefilled Syringes
o Plastic Prefilled Syringes
o Glass Prefilled Syringes
Make an Enquiry before Buying @ https://www.wiseguyreports.com/enquiry/562722-auto-injectors-global-market-outlook-2015-2022
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Purchase a Licensed Copy @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=562722
Table of Content
Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Auto Injectors Market, By Device
5.1 Introduction
5.2 Smart Autoinjectors
5.3 Product Specific Autoinjectors
5.4 Manual Injection Autoinjectors
5.5 Disposable Autoinjectors
5.6 Reusable Autoinjectors
5.7 Variable Dose Autoinjectors
5.8 Automated Injection Autoinjectors
6 Global Auto Injectors Market, By Product Type
6.1 Introduction
6.2 Standardized Auto-injectors
6.3 Customized Auto-injectors
7 Global Auto Injectors Market, By Therapeutic Application
7.1 Introduction
7.2 Autoimmune Diseases
7.3 Anaphylaxis
7.4 Anticoagulants
7.5 Neurology
7.6 Rheumatoid Arthritis
7.7 Infectious Diseases
7.8 Reproductive Health
7.9 Hormones
7.10 Hematopoietics
7.11 Multiple Sclerosis
7.12 Emergency Medicine
7.13 Other Therapeutic Application
8 Global Auto Injectors Market, By Primary Drug Container
8.1 Introduction
8.2 Cartridges
8.2.1 Single Chamber Cartridge
8.2.2 Dual Chamber Cartridge
8.3 Vials
8.4 Prefilled Syringes
8.4.1 Plastic Prefilled Syringes
8.4.2 Glass Prefilled Syringes
Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Unilife Corporation
11.2 Novartis International AG
11.3 Becton, Dickinson and Company
11.4 Antares Pharma, Inc.,
11.5 Mylan, Inc.
11.6 Adamis Pharmaceuticals Corp
11.7 Hospira Inc
11.8 Scandinavian Health Limited (SHL) Group
11.9 Sanofi SA
11.10 Itelliject Inc
11.11 Pfizer, Inc.
11.12 Lincoln Medical Ltd
11.13 Ypsomed Holdings AG
11.14 ALK Abello
11.15 Teva Pharmaceuticals Ltd
11.16 Biogen Idec, Inc.
Continued....
Contact US: sales@wiseguyreports.com Ph: +1-646-845-9349 (US), Ph: +44 208 133 9349 (UK)
Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
